Functional soluble CD100/sema4D released from activated lymphocytes: Possible role in normal and pathologic immune responses

Blood

Volumn 97, Issue 11, 2001, Pages 3498-3504

  Wang, Xiaosong ^a   Kumanogoh, Atsushi ^a   Watanabe, Chie ^a   Shi, Wei ^a   Yoshida, Kanji ^a   Kikutani, Hitoshi ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD100 PROTEIN; CD72 ANTIGEN; IMMUNOGLOBULIN G1; MEMBRANE PROTEIN; SEMA4D PROTEIN; SEMAPHORIN; T LYMPHOCYTE ANTIBODY; T LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CONTROLLED STUDY; IMMUNE RESPONSE; LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SUPERNATANT;

EID: 0035383772     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.11.3498     Document Type: Article

References (41)

1. Semaphorin Nomenclature Committee. Unified nomenclature for the semaphorins/collapsins. Cell. 1999;97:551-552.
2. Yu H-H, Kolodkin AL. Semaphorin signaling: a little less per-plexin. Neuron. 1999;22:11-14.
3. Kolodkin AL, Matthes DJ, O'Connor TP, Patel NH, Bentley D, Goodman CS. Fascilin IV: sequence, expression, and function during growth cone guidance in the grasshopper embryo. Neuron. 1992;9:831-845.
4. Kolodkin AL, Matthes DJ, Goodman CS. The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules. Cell. 1993;75:1389-1399.
5. Luo Y, Raible D, Raper JA. Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones. Cell. 1993;75:217-227.
6. Dodd J, Schuchardt A. Axon guidance: a compelling case for repelling growth cones. Cell. 1995; 81:471-474.
7. Kitsukawa T, Shimono A, Kawakami A, Kondoh H, Fujisawa H. Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Development. 1995;121:4309-4318.
8. Behar O, Golden JA, Mashimo H, Schoen FJ, Fishman MC. Semaphorin III is needed for normal patterning and growth of nerves, bones and heart. Nature. 1996;383:525-528.
9. Roche J, Boldog F, Robinson M, et al. Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin. Oncogene. 1996; 12:1289-1297.
10. Sekido Y, Bader S, Latif F, et al. Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns. Proc Natl Acad Sci U S A. 1996;93:4120-4125.
11. Furuyama T, Inagaki S, Kosugi A, et al. Identification of a novel transmembrane semaphorin expressed on lymphocytes. J Biol Chem. 1996;271: 33376-33381.
12. Hall KT, Boumsell L, Schultze JL, et al. Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. Proc Natl Acad Sci U S A. 1996;93:11780-11785.
13. Bougeret C, Mansur IG, Dastot H, et al. Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation. J Immunol. 1992;148:318-323.
14. Delaire S, Elhabazi A, Bensussan A, Boumsell L. CD100 is a leukocyte semaphorin. Cell Mol Life Sci. 1998;54:1265-1276.
15. Kumanogoh A, Watanabe C, Lee I, et al. Identification of CD72 as a lymphocyte receptor for the class IV Semaphorin CD100: a novel mechanism for regulating B-cell signaling. Immunity. 2000;13: 621-631.
16. Tamagnone L, Artigiani S, Chen H, et al. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell. 1999;99:71-80.
17. Maestrini E, Tamagnone L, Longati P, et al. A family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptor. Proc Natl Acad Sci U S A. 1996;93:674-678.
18. Shi W, Kumanogoh A, Watanabe C, et al. The class IV semaphorin CD100 plays a nonredundant role in the immune response: Defective B and T-cell activation in CD100-deficient mice. Immunity. 2000;13:633-642.
19. Adachi T, Flaswinkel H, Yakura H, Reth M, Tsubata T. The B-cell surface protein CD72 recruits the tyrosine phosphatase SHP-1 upon tyrosine phosphorylation. J Immunol. 1998;160: 4662-4665.
20. Pan C, Baumgarth N, Parnes JR. CD72-deficient mice reveal nonredundant roles of CD72 in B-cell development and activation. Immunity. 1999;11: 495-506.
21. Fremeaux-Bacchi V, Aubry JP, Bonnefoy JY, Kazatchkine MD, Kolb JP, Fischer EM. Soluble CD21 induces activation and differentiation of human monocytes through binding to membrane CD23. Eur J Immunol. 1998;26:4268-4274.
22. Delespesse G, Suter U, Mossalayi D, et al. Expression, structure, and function of the CD23 antigen. Adv Immunol. 1991;49:149-191.
23. Hintzen RQ, de Jong R, Lens SM, van Lier RA. CD27: marker and mediator of T-cell activation? Immunol Today. 1994;15:307-311.
24. Bazil V, Horejsi V. Shedding of CD44 adhesion molecule from leucocytes induced by anti-CD44 monoclonal antibody simulating the effect of a natural receptor ligand. J Immunol. 1992;149: 747-753.
25. Leca G, Mansur SE, Bensussan A. Expression of VCAM-1 (CD106) by a subset of TCR gamma delta-bearing lymphocyte clones. J Immunol. 1995;154:1069-1077.
26. Hughes DPM, Crispe IN. A naturally occurring soluble iosform of murine Fas generated by alternative splicing. J Exp Med. 1995;182:1395-1401.
27. Cheng J, Zhou T, Liu C, et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science. 1994;263:1759-1762.
28. Herold C, Bismuth G, Bensussan A, Boumsell L. Activation signals are delivered through two distinct epitopes of CD100, a unique 150 kDa human lymphocyte surface structure previously defined by BB18 mAb. Int Immunol. 1995;7:1-8.
29. Herold C, Elhabazi A, Bismuth G, Bensussan A, Boumsell L. CD100 is associated with CD45 at the surface of human T lymphocytes. J Immunol. 1996;157:5262-5268.
30. Jabs DA, Prendergast RA. Reactive lymphocytes in lacrimal gland and vasculitic renal lesions of autoimmune MRL/Ipr mice express L3T4. J Exp Med. 1987;166:1198-1203.
31. Theofilopoulos AN, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol. 1985;37:269-390.
32. Hoffman RW, Alspaugh MA, Waggie KS, Durham JB, Walker SE. Sjogren's syndrome in MRL/I and MRL/n mice. Arthritis Rheum. 1984;27:157-165.
33. Andrews BS, Eisenberg RA, Theofilopoulos AN, et al. Spontaneous murine lupus-like sydromes: clinical and immunopathological manifestations in several strains. J Exp Med. 1978;148:1198-1215.
34. Adams RH, Lohrum M, Klostermann A, Betz H, Puschel AW. The chemorepulsive activity of secreted semaphorins is regulated by furin-dependent proteolytic processing. EMBO J. 1997;16: 6077-6086.
35. Arribas J, Coodly L, Vollmer P, Kishimoto TK, Rose-Jhon S, Massague J. Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. J Biol Chem. 1996;271:11376-11382.
36. Robache-Gallea S, Bruneau JM, Robbe H, Morand V, Capdevila C, Bhatmagar N. Partial purification and characterization of a tumor necrosis factor-alpha converting activity. Eur J Immunol. 1997;27:1275-1282.
37. Blobel CP. Metalloprotease-disintegrins: links to cell adhesion and cleavage of TNFalpha and notch. Cell. 1997;90:589-592.
38. Korganow AS, Ji H, Mangialaio S, et al. From systemic T-cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity. 1999;10:451-461.
39. Madaio MP, Carlson J, Cataldo J, Ucci A, Migliorini P, Pankewycz O. Murine monoclonal anti-DNA antibodies bind directly to glomerular antigens and form immune deposits. J Immunol. 1987;138:2883-2889.
40. Sabbaga J, Line SR, Potocnjak P, Madaio MP. A murine nephritogenic monoclonal anti-DNA auto-antibody binds directly to mouse laminin, the major non-collagenous protein component of the glomerular basement membrane. Eur J Immunol. 1989;19:137-142.
41. Lake RA, Staines NA. A monoclonal DNA-binding autoantibody causes a deterioration in renal function in MRL mice with lupus disease. Clin Exp Immunol. 1988;73:103-110.